Does including machine learning predictions in ALS clinical trial analysis improve statistical power?

OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease which leads to progressive muscle weakness and eventually death. The increasing availability of large ALS clinical trial datasets have generated much interest in developing predictive models for disease progression. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Nina, Manser, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545604/
https://www.ncbi.nlm.nih.gov/pubmed/32862509
http://dx.doi.org/10.1002/acn3.51140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545604/
https://www.ncbi.nlm.nih.gov/pubmed/32862509
http://dx.doi.org/10.1002/acn3.51140

Ejemplares similares